Review of Novel Therapies and Update for Takayasu Arteritis and ANCA-Associated Vasculitis with Relevance to the Asia Pacific Region

Abstract

The clinical studies of Takayasu’s arteritis and antineutrophil cytoplasm antibodies (ANCA)-associated vasculitis are very active in the Asia Pacific region. The results of these studies give us a more comprehensive understanding of these vasculitis, which may not only change the management and long-term prognosis of the disease, but also reduce complications and prolonged survival time. Therefore, we summarize the results of these studies that were led or actively participated by investigators in the Asia Pacific region from 2020 to 2021, mainly focusing on the clinical characteristics and management.